Ifosfamide in Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|65|2|50-54

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.2, 2003-11, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Ifosfamide in Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 46-49

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite

Phase II Study of Irinotecan and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 306-311

Karger

Access to resources Recommend Favorite

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite